rf-fullcolor.png

 

December 4, 2025
by Jason Scott

Recon: FDA to reduce number of studies needed for most drugs; CDC advisers delay vote on hepatitis B vaccine

Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.
 
In Focus: US
  • Trump has ‘shaken the hell’ out of the 80-year research pact between the government and universities. What now? (STAT)
  • Top Senate health leader calls CDC vaccine panel ‘totally discredited’ (STAT)
  • FDA to lower number of trials required for approval of drugs, other medical products (STAT)
  • Exclusive: Trump administration pushes end-of-term deadline for ‘most favored nation’ promises (Endpoints)
  • Prasad's claim of 10 Covid vaccine deaths may be an overcount, FDA sources say (Endpoints)
  • FDA names Tracy Beth Høeg, who helped lead Covid shot investigation, as acting CDER chief (Endpoints)
In Focus: International
  • In reciprocal licensing pact with Kelun, Crescent's PD-1xVEGF heads to China (Endpoints)
  • ARCH, Lilly Asia Ventures return to back US-China startup SciNeuro (Endpoints)
  • Novo Nordisk gears up for December Ozempic launch in India, sources say (Reuters)
  • US signs pact with Kenya under 'America First' global health plan (Reuters)
  • UK MHRA’s Medtech Regulatory Update Must Keep Future EU MDR Changes In Mind (MedTech Insight)
Pharma & Biotech
  • A single shot of HPV vaccine may be enough to fight cervical cancer, study finds (STAT)
  • Paradigm Health, seeking to use AI to enroll clinical trials, partners with Roche (STAT)
  • Nationwide Children’s gene therapy shows early promise after Taysha pullback (Endpoints)
  • Mark Cuban seeks Trump’s backing for drug fee relief to spur generics manufacturing (Reuters)
Medtech
  • Women can self-test at home for cervical cancer virus, new guidelines say (Reuters)
  • Medtronic’s Hugo surgical robot earns FDA clearance (MedTech Dive)
  • Medtronic launches insulin delivery system with Abbott-made sensor (MedTech Dive)
  • Akura Medical raises $53M to advance thrombectomy portfolio (MedTech Dive)
  • PitchBook: AI tuck-in deals to drive M&A acceleration in 2026 (MedTech Dive)
  • Medtronic names Jeb Denny as chief medical officer for acute care and monitoring (MedTech Dive)
  • Truvian Secures FDA Clearance For Benchtop Blood-Testing System, Eyes Full Launch H2 2026 (MedTech Insight)
Food & Nutrition
  • European Union Reaches a Deal to Allow Gene Editing in Farming (Bloomberg)
  • The chemistry of comfort: Inside the rise of nostalgic snacks (Food Dive)
Government, Regulatory & Legal
  • What West Virginia teens lost when CDC cuts ended their fight against Big Tobacco (STAT)
  • CDC vaccine advisers appear likely to recommend delaying hepatitis B vaccine birth dose (STAT)
  • Daiichi Sankyo avoids payout in long-running patent dispute with Pfizer’s Seagen (Endpoints)
  • Obamacare premium spikes could drive off enrollees, most want subsidy extension, KFF finds (Reuters)
  • Change To Medicare Diabetes Supply Payments Raises Access And Pricing Concerns (MedTech Insight)
  • FDA’s Tobacco Civil Money Penalty Authority, cont’d: Not Backing Down (FDA Law Blog)
Regulatory Recon is our regular intelligence briefing for the regulatory affairs space, bringing you the top regulatory, biopharma and medtech news stories from around the globe. Regulatory Recon is published each week on Monday, Tuesday and Thursday.
 
A story’s inclusion in Regulatory Recon does not imply endorsement by Regulatory Focus or RAPS.
×

Welcome to the new RAPS Digital Experience

We have completed our migration to a new platform and are pleased to introduce the updated site.

What to expect: If you have an existing login, please RESET YOUR PASSWORD before signing in. After you log in for the first time, you will be prompted to confirm your profile preferences, which will be used to personalize content.

We encourage you to explore the new website and visit your updated My RAPS page. If you need assistance, please review our FAQ page.

We welcome your feedback. Please let us know how we can continue to improve your experience.